等待期死亡率与体外膜肺氧合桥接肺移植
基于美国器官共享联合网络数据库,2016年4月至2021年12月共634例在列名时接受ECMO支持的患者中,445例(70%)成功桥接至移植,148例(23%)在等待期死亡,41例(6.5%)因其他原因移除。高容量中心患者存活至移植的可能性高24%,等待期死亡风险低44%;成功桥接至移植者中,低容量与高容量中心生存无差异。
要点
- ECMO桥接肺移植患者中约四分之一可能在等待期死亡。
- 高容量中心患者存活至移植可能性高24%,等待期死亡风险低44%。
- 成功桥接至移植后,低容量与高容量中心生存无差异。
核心结论
- ECMO是将选定的高危患者桥接至肺移植的合适策略。
- 在有意向移植而接受ECMO的患者中,约四分之一可能无法存活至移植。
- 需要高级支持策略的高危患者在高容量中心桥接时可能更可能存活至移植。
研究设计与样本
- 使用美国器官共享联合网络数据库识别所有在列名时接受ECMO支持的患者。
- 采用偏倚缩减逻辑回归进行单变量分析,采用病因特异性风险模型确定变量对结局风险的影响。
- 2016年4月至2021年12月共634例患者符合纳入标准。
主要发现
- 634例患者中,445例(70%)成功桥接至移植,148例(23%)在等待期死亡,41例(6.5%)因其他原因被移除。
- 单变量分析发现等待期死亡率与血型、年龄、体重指数、血清肌酐、肺分配评分、等待名单天数、美国器官共享联合网络区域及在低容量中心列名相关。
- 病因特异性风险模型显示,高容量中心患者存活至移植的可能性高24%,等待期死亡风险低44%。
- 成功桥接至移植的患者中,低容量与高容量中心的生存无差异。
临床怎么用
- ECMO是将选定的高危患者桥接至肺移植的合适策略。
- 需要高级支持策略的高危患者在高容量中心桥接时可能更可能存活至移植。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Use of extracorporeal membrane oxygenation (ECMO) as bridge to lung transplant has increased. However, little is known about patients placed on ECMO who die while on the waiting list. Using a national lung transplant data set, we investigated variables associated with waitlist mortality of patients bridged to lung transplant. METHODS: All patients supported on ECMO at time of listing were identified using the United Network for Organ Sharing database. Univariable analyses were performed using bias-reduced logistic regression. Cause-specific hazard models were used to determine the effect of variables of interest on hazard of outcomes. RESULTS: From April 2016 to December 2021, 634 patients met inclusion criteria. Of these, 445 (70%) were successfully bridged to transplant, 148 (23%) died on the waitlist, and 41 (6.5%) were removed for other reasons. Univariable analysis found associations between waitlist mortality and blood group, age, body mass index, serum creatinine, lung allocation score, days on waitlist, United Network for Organ Sharing region, and being listed at a lower-volume center. Cause-specific hazard models demonstrated that patients at high-volume centers were 24% more likely to survive to transplant and 44% less likely to die on the waitlist. Among patients who were successfully bridged to transplant, there was no difference in survival between low- and high-volume centers. CONCLUSIONS: ECMO is an appropriate strategy to bridge selected high-risk patients to lung transplant. Of those placed on ECMO with intent to transplant, about one quarter may not survive to transplantation. High-risk patients requiring advanced support strategies may be more likely to survive to transplant when bridged at a high-volume center.
引用
- Deitz RL, Emerel L, Chan EG, et al. Waitlist Mortality and Extracorporeal Membrane Oxygenation Bridge to Lung Transplant. Ann Thorac Surg. 2023. PMID: 37004804. doi:10.1016/j.athoracsur.2023.02.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。